Streamlining Screening to Treatment: The Hepatitis C Cascade of Care at Kaiser Permanente Mid-Atlantic States
| Autor: | Carla V. Rodriguez, M. Cabell Jonas, Dana A Sloane, Bradley J. Winston, Bernadette Loftus, Jacquelyn L. Redd |
|---|---|
| Rok vydání: | 2015 |
| Předmět: |
Microbiology (medical)
Liver Cirrhosis Male medicine.medical_specialty Hepacivirus Hepatitis C virus medicine.disease_cause Physician referral Cohort Studies 03 medical and health sciences 0302 clinical medicine Internal medicine medicine Humans Mass Screening 030212 general & internal medicine Mid-Atlantic Region Mass screening Aged biology business.industry virus diseases Hepatitis C Hepatitis C Antibodies Middle Aged medicine.disease biology.organism_classification digestive system diseases Infectious Diseases Immunology Coinfection 030211 gastroenterology & hepatology Female Transient elastography business Cohort study |
| Zdroj: | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 62(10) |
| ISSN: | 1537-6591 |
| Popis: | Hepatitis C virus (HCV) screening is recommended for patients at risk and/or born during 1945-1965, but screening gaps persist. This new program screens target populations and enhances care linkage for chronically HCV-infected patients. Kaiser Permanente Mid-Atlantic States created a comprehensive HCV screening pathway, supported by a HCV care coordinator. The testing pathway includes HCV antibody (Ab), automatic HCV RNA for Ab-positive patients, coinfection and liver health tests, vibration-controlled transient elastography (VCTE), and a physician referral. A total of 11 200 patients were screened; 3.25% were HCV Ab positive, and 100% of Ab-positive patients received HCV RNA testing. Of HCV Ab-positive patients, 75.9% had chronic HCV, of which 80.8% underwent VCTE. HCV diagnosis was communicated to 94% of patients, and 70.9% had HCV documented in the electronic health record. The pathway shows promise in closing gaps, including improving HCV RNA testing, communicating diagnoses, and assessing liver fibrosis. Improved testing and linkage could increase curative treatment access. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|